Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers
2008 · Journal of Clinical Oncology · 299 citations
https://doi.org/10.1200/jco.2007.15.8659
B
B. Norris
BC Cancer Agency(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
2.9K
Citations
16
h-index
20
i10-index
B. Norris is an academic researcher from BC Cancer Agency. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology & HER2/EGFR in Cancer Research. The author has an h-index of 16, co-authored 25 publications.
Papers by this author
worksRandomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163
2009 · Journal of Clinical Oncology · 260 citations
https://doi.org/10.1200/jco.2008.21.3033
New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up
2008 · Breast Cancer Research and Treatment · 34 citations
https://doi.org/10.1007/s10549-007-9887-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat